MAPT and Parkinson disease: Indeed, in PD, levels of neurodegeneration-related CSF biomarkers, namely, α-synuclein (α-syn), amyloid-β42 (Aβ42), total tau (t-tau), and phosphorylated-181-tau (p-tau), may have either diagnostic or prognostic value (2–5).